36 / 144
36
PERGUNTAS & RESPOSTAS
EMD
- Edema Macular Diabético
Referências
1. Pulido JS, Krachmer J. Retina, Choroid, and Vitreous – The Requisites in Ophthalmolo-
gy. 2002, pp 31-50.
2. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for seve-
re vitreous hemorrhage in diabetic retinopathy: two-year results of a randomized trial
- Diabetic Retinopathy Vitrectomy Study report 2. Arch Ophthalmol. 1985;103:1644-
1652.
3. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiology Study of Diabetic Reti-
nopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less
than 30 years. Arch Ophthalmol. 1984;102:520-526.
4. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiology Study of Diabetic Reti-
nopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or
more years. Arch Ophthalmol. 1984;102:527-532.
5. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiology Study of Diabetic Reti-
nopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and asso-
ciated risk factors in type 1diabetes. Ophthalmology. 1998;105:1801-1815.
6. Diabetes Control and Complications Trial Research Group. The effect of intensive treat-
ment of diabetes on the development and progression of long-term complications in
insulin-dependent diabetes mellitus. N Engl J Med.1993;329:977-986.
7. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control
with sulphonylureas or insulin compared with conventional treatment and risk of com-
plications in patients with type 2 diabetes (UKPDS 33). Lancet.1998;352:837-853.
8. Regillo DC, Brown GC, Flynn HW. Vitreoretinal Disease-the essentials. 1999,133-159.
9. Ferris FL III. Early photocoagulation in patients with either type I or type II diabetes.
EDTRS Report 24. Early Treatment Diabetic Retinopathy Study Research Group. Trans
Am Ophthalmol Soc. 1996;94:505-537.